|Bid||43.20 x 1200|
|Ask||45.00 x 900|
|Day's range||44.02 - 44.84|
|52-week range||38.22 - 62.78|
|Beta (5Y monthly)||0.46|
|PE ratio (TTM)||13.67|
|Earnings date||30 Nov 2022 - 05 Dec 2022|
|Forward dividend & yield||1.04 (2.38%)|
|Ex-dividend date||14 Nov 2022|
|1y target est||54.36|
Kroger (KR) could produce exceptional returns because of its solid growth attributes.
Kroger said it has made several attempts since February to negotiate with the pharmacy benefit manager for a "more equitable and fair contract that lowers cost, increases access, and delivers greater transparency, but there has been little to no progress to date". Kroger said more than 90% of Kroger Health's customers will not be affected by a termination of the deal, but if a new agreement is not reached by Dec. 31, most Express Scripts' commercial customers won't be able to fill prescriptions at Kroger stores.
Centene, Diamondback, Energy, The Kroger, Wells Fargo and United Rentals are part of Zacks Value Trader blog.